DNA-methylation profiling distinguishes malignant melanomas from benign nevi. - Wikidata - wikimedia - TriplyDB

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

http://www.wikidata.org/entity/Q34775571

about

Epigenetic mechanisms involved in melanoma pathogenesis and chemoresistance Epigenetic regulation in human melanoma: past and future Emerging technologies for studying DNA methylation for the molecular diagnosis of cancer Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis.DNA methylation characteristics of primary melanomas with distinct biological behaviour.Genetics and epigenetics of the skin meet deep sequence.Formalin fixation in the '-omics' era: a primer for the surgeon-scientist.Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma DNA methylation profiles in primary cutaneous melanomas are associated with clinically significant pathologic features.Integrative genomics identifies gene signature associated with melanoma ulceration.DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma IL2 Inducible T-cell Kinase, a Novel Therapeutic Target in Melanoma DNA methylation subgroups in melanoma are associated with proliferative and immunological processes Supratentorial and spinal pediatric ependymomas display a hypermethylated phenotype which includes the loss of tumor suppressor genes involved in the control of cell growth and death.Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma Aberrant DNA methylation in melanoma: biomarker and therapeutic opportunities.Defining the role of TRIP6 in cell physiology and cancer.Epigenetic-dependent regulation of drug transport and metabolism: an update.Skinomics: past, present and future for diagnostic microarray studies in dermatology.Epigenetics of human melanoma: promises and challenges.Cellular Mechanisms of Oxidative Stress and Action in Melanoma.Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.Melanocytic nevi and melanoma: unraveling a complex relationship.Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation.Epigenetic alterations in sporadic basal cell carcinomas.DNA methylation/hydroxymethylation in melanoma.Genome-wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma.[Dysplastic melanocytic nevus].

P2860

Q26778761-0E02ED00-ED80-4931-A75C-8EB8BDCBF0DE Q28085681-36EDB043-9A1B-4A57-9E9B-BFC54D050213 Q28087759-A5FE4536-5149-432F-AD2E-071E5FC045F6 Q31089944-3520E66C-8975-47A8-803A-C770F575AC8A Q33617915-1FACB98B-7B40-4A59-9B9B-59D79A11935E Q33904361-6B13E569-1A82-4404-977C-A42696862B8C Q34263623-99F7F7E1-C3A5-4E6A-9C0A-285FD99CF9BD Q34299814-54B11BD2-3217-453B-B5D5-57F78A1A0886 Q34416046-B153E11A-6F31-4FC8-BF12-7ACE222B4A6D Q34575854-4766A3B8-9B6E-4786-81D8-136D2A39BC85 Q35000317-CAE50F3F-8A60-4C16-9EE2-3F5CC1BFFA0E Q35229597-87941D5F-0645-4901-B834-29FE78C6356F Q35564248-2328FEFD-55A0-4C6C-B887-EB5AC1E537FF Q35834765-7F292D50-3B73-440F-A8E5-5A70A0389DFC Q35863933-0EE5FB94-B8CC-4B50-A303-69428B268FD9 Q37218158-4F18DA20-D6F6-4C49-A316-C1EEB2E9CE68 Q37737945-80CDADF4-DFE6-40B2-8009-3533F8DCBABA Q37952876-8A7A480D-0F77-44CC-B722-3FB159293E54 Q38042440-1066D88C-874D-4CFA-B788-47F33F8A4950 Q38154933-4B9AD953-693A-42B9-9137-21F3DD93D649 Q38217482-91B01DF5-5F45-4FE1-91C2-C2502D025E88 Q38524702-15751C35-4FA7-4CB5-9DEC-A3AA15FFA27E Q38723959-14027D57-BFEE-473E-8577-C8C6B5023254 Q38730348-C1992939-CF67-4B31-9670-829150437797 Q38906998-A2ABA9D1-A24E-4881-8C50-2E63A8C902D5 Q42454854-B4E838FF-FB38-44C3-9AD0-0E65DA6C067B Q47119104-5F735622-5D35-4EAB-A8BE-9B9731787BBA Q51066007-81962DF3-4378-4818-9B78-E939DA672094 Q53643440-FFD796F1-E345-447A-8174-230C24395CE5

P2860

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

http://www.wikidata.org/entity/Q34775571

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

@ast

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

@en

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

@nl

type

label

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

@ast

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

@en

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

@nl

prefLabel

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

@ast

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

@en

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

@nl

P1433

Q34775571-29F1593D-AC32-4031-A781-8ABDBDC8D3FC

P1476

Q34775571-A1DAE253-8C63-4829-8A8F-F352FF9232FA

P2093

Q34775571-13CDD4DD-35F4-4315-B528-405F96E8526B

Q34775571-14660C1F-B37A-4332-BE57-6EC62471A4DD

Q34775571-2E178664-7194-4347-A39A-B74A18C0BA5D

Q34775571-315BA52F-F2A8-4C53-83B4-E9A4EB95FEA6

Q34775571-3EB24C8A-A6F3-4E06-AF23-DCC2393CE6AD

Q34775571-5E4C982F-5AC5-412C-AC42-8951AD46CD05

Q34775571-7C82E43F-3843-4A8E-921E-7EB9F371C15A

Q34775571-9023EEE0-F810-47DC-83A4-EAF531CB75D8

Q34775571-9167963B-8C76-4BFF-8AB6-1250FA0805DF

Q34775571-B40E9EF1-25C5-4B73-908A-287DE2438BA6

P2860

Q34775571-02196746-EF1F-4188-BB4F-69C51C062F56

Q34775571-056BC019-DF5B-49E6-B926-16087D42691D

Q34775571-1045CD09-E0BE-43CA-965C-02DE157EB855

Q34775571-132E8352-DF3F-454D-8C82-76BBDD301C2E

Q34775571-237F27A8-E208-4132-9F91-281C06CD7770

Q34775571-24C55C64-157E-4C90-A8CD-A9A4CBD35D79

Q34775571-37151266-8296-4ED4-952F-99E963B7FE2E

Q34775571-3E8211B1-DAA4-4490-92A1-67A76E9D9BEE

Q34775571-3EDF14DB-AA6D-4DD1-90E9-5F02DE9161A1

Q34775571-4194ABA1-0EF5-4F7A-8D1C-02A5189DACC0

P304

Q34775571-7DD903CB-86C5-4D01-8B9B-3F87A626969E

P31

Q34775571-89B4D86E-4755-4498-94A7-D89E8ADCE813

P356

Q34775571-F00F0CE3-1253-4D1C-853A-CD726A391454

P433

Q34775571-B64AD28E-A285-4D12-95B3-D8F70BF5EF5C

P478

Q34775571-A6EA50BB-3B7D-4E0A-892C-56670685A1BB

P50

Q34775571-CE8E5296-6161-4CB3-9E77-68BF599AEB23

Q34775571-F76E4258-73BF-4259-BA96-0D957943C5DF

P577

Q34775571-DC64BFD0-1E4E-485D-B727-75DB87C2B60E

P5875

Q34775571-DAA50AB6-5232-48AA-8F67-17082C8D605A

P698

Q34775571-A543186F-5E9B-4686-A3CA-3F5B47BB550A

P921

Q34775571-92B64804-07DF-452C-B4D5-3D8DA2A4C4EF

P932

Q34775571-463C6916-1FB9-48C5-928A-34BC080B6FD7

P356

J.1755-148X.2011.00828.X

P1433

Pigment Cell & Melanoma Research

P1476

DNA-methylation profiling distinguishes malignant melanomas from benign nevi.

@en

P2093

Craig Carson

http://www.w3.org/2001/XMLSchema#string

David W Olilla

http://www.w3.org/2001/XMLSchema#string

Honglin Hao

http://www.w3.org/2001/XMLSchema#string

Kathleen Conway

http://www.w3.org/2001/XMLSchema#string

Nancy E Thomas

http://www.w3.org/2001/XMLSchema#string

Pamela A Groben

http://www.w3.org/2001/XMLSchema#string

Pei Fen Kuan

http://www.w3.org/2001/XMLSchema#string

Sharon N Edmiston

http://www.w3.org/2001/XMLSchema#string

Xin Zhou

http://www.w3.org/2001/XMLSchema#string

Zakaria S Khondker

http://www.w3.org/2001/XMLSchema#string

P2860

TRIP6 is a RIP2-associated common signaling component of multiple NF-kappaB activation pathways

Molecular cloning of the human T-lymphocyte surface CD2 (T11) antigen

Human epidermal growth factor (EGF) module-containing mucin-like hormone receptor 3 is a new member of the EGF-TM7 family that recognizes a ligand on human macrophages and activated neutrophils

Control of developmental regulators by Polycomb in human embryonic stem cells

Epigenetic silencing of novel tumor suppressors in malignant melanoma

Signalling pathways and molecular interactions of NOD1 and NOD2

RUNX3 has an oncogenic role in head and neck cancer

Diagnosis of multiple cancer types by shrunken centroids of gene expression

Gene silencing in cancer in association with promoter hypermethylation

HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease.

P304

352-360

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1755-148X.2011.00828.X

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P50

Marianne Berwick

P577

2011-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50286927

http://www.w3.org/2001/XMLSchema#string

P698

21375697

http://www.w3.org/2001/XMLSchema#string

P921

DNA methylation

P932

3073305

http://www.w3.org/2001/XMLSchema#string